← FDA Drug Approvals (Drugs@FDA)

NISOLDIPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMTA · Approved 2023-04-10

Drug application

FDA Application #

ANDA216606

Application type

Abbreviated New Drug Application (Generic)

Brand name

NISOLDIPINE

Generic name

Nisoldipine

Active ingredients

NISOLDIPINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

AMTA

First approval

2023-04-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown